Amner Sanchez Montenegro

Amner Sanchez Montenegro

Auto-generated profile, based on publicly available information

Amner Sanchez Montenegro

Department of Disaster Management, Lambayeque Regional Hospital, Lambayeque, Peru

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2026 in Drugs & Therapy Perspectives
Verified
Journal Article
Open access
PDF file
IJIsabela Jimenez
Isabela Jimenez
CVCarlos Valladares
Carlos Valladares
CVCarlos E. Núñez Vásquez
Carlos E. Núñez Vásquez
AMAmner Sanchez Montenegro
Amner Sanchez Montenegro
JCJia Ee Chia
Jia Ee Chia
EYEmanuel Nina Yupanqui
Emanuel Nina Yupanqui
Background and Objective Prolonged intravenous (IV) antibiotics are standard for brain abscess management but prolong hospital stays and increase costs. Intravenous-to-oral switch (IVOS) has been proposed as a safe alternative. This systematic review aimed to assess the effectiveness of IVOS strategies and compare clinical outcomes according to duration of IV exposure prior to oral switch. Methods A systematic review and meta-analysis was conducted according to PRISMA guidelines. Five electronic databases were searched (PubMed, Embase, Scopus, Web of Science, and Cochrane Library) up to May 11, 2025. Eligible studies included retrospective or prospective cohort studies in patients aged ≥ 16 years with brain abscess, reporting at least one predefined clinical outcome. Studies were excluded if they did not evaluate oral antibiotic therapy or did not report extractable outcome data. Outcomes assessed included treatment success (primary), recurrence, adverse events, and hospital stay. Risk of bias was evaluated using the ROBINS-I V2 tool. Exposure thresholds for IV duration were retained as defined within each individual study, given the absence of a uniform protocol across cohorts. Results Five retrospective cohort studies comprising 488 patients were included; four provided sufficient data for meta-analysis. Median time to oral switch ranged from 9 to 19 days (reported in three studies). Overall treatment success was 70.2% (321/457), with 83.2% (154/185) in shorter IV exposure groups and 61.4% (167/272) in longer IV exposure groups (study defined). In pooled analysis, shorter IV exposure (study-defined thresholds) was associated with higher treatment success compared with longer IV exposure (OR 2.69; 95% CI 1.66–4.37; p < 0.001; I2 = 0%); however, exposure thresholds and outcome definitions varied across studies, and the pooled estimate reflects a directional association rather than the effect of a standardized intervention. Sensitivity analysis confirmed robustness, and funnel plot inspection revealed no major publication bias, though this assessment was limited by the small study number. Conclusions IVOS strategies appear to be a safe and potentially effective approach for selected patients with brain abscess, potentially reducing hospitalization without compromising outcomes. Evidence remains limited by retrospective design and moderate-to-serious risk of bias. Prospective trials are warranted. Registration The review was prospectively registered in PROSPERO (CRD420251060028).